NIDC News
Our NIDC News reports the latest developments in U.S. Department of Energy’s isotope production efforts, university partnerships, facility improvements, staff news, and other notable center activities as they occur. Stay Connected
March 28, 2023
Two scientists supported by the Department of Energy Isotope Program have been elected fellows of the American Association for the Advancement of Science.
Dr. Stosh Kozimor, who serves as principal investigator for the Office of Science Heavy Element Chemistry Program and works with the Isotope Production team at Los Alamos National Laboratory, and Dr. Sandra Davern, who leads the Radioisotope…
March 9, 2023
Interested in learning about the regulatory landscape for using the DOE Isotope Program’s (DOE IP) accelerator-produced Ac-225 in your research? Please join us on Tuesday, March 21, 2023, from 2-4 p.m. (Eastern) for the DOE IP Virtual Roundtable on Accelerator-Produced Ac-225 with the Nuclear Regulatory Commission (NRC).
The DOE IP is increasing routine supply of Ac-225. One…
February 15, 2023
The DOE Isotope Program (DOE IP) has released a report resulting from the 2022 Workshop on Artificial Intelligence for Isotope R&D and Production. The purpose of the workshop was for DOE IP to further its understanding of the potential roles for and subsequent opportunities to incorporate AI into its activities. The workshop brought together over 80 participants from both the AI and isotope…
February 9, 2023
Students will perform graduate research at national laboratories
The U.S. Department of Energy’s (DOE) Office of Science is pleased to announce that the Office of Science Graduate Student Research (SCGSR) program is now accepting applications for the 2023 Solicitation 1 cycle. Applications are due 5:00pm Eastern Time on Wednesday, May 3, 2023.
SCGSR application assistance…
January 20, 2023
The NIDC, on behalf of the DOE Isotope Program, seeks input from commercial stakeholders on anticipated isotope product needs and potential supply shortages in the next five years.
With this valuable information, the DOE IP will gain a clearer understanding of future market demand and, as a result, can better serve industrial and research entities by tailoring isotope production to meet…
November 16, 2022
The DOE Office of Science is excited to announce it is accepting proposals for the 2023 DOE Office of Science Early Career Research Program to support the research of outstanding scientists early in their careers. The program will support over 80 early career researchers at U.S. academic institutions and DOE National Laboratories.
To be eligible for the program, a researcher must…
November 2, 2022
The DOE Isotope Program is excited to announce the addition of the University of Wisconsin Cyclotron Research Group to the University Isotope Network. Supported by DOE IP funding, the UW Cyclotron Research Group have developed four new production lines of isotopes at their facility, now available through the NIDC product catalog. Manganese-52g, Bromine-76, Bromine-77, and Yttrium-86…
October 24, 2022
The U.S. Department of Energy (DOE), in coordination with Oak Ridge National Laboratory, today held a groundbreaking for the U.S. Stable Isotope Production and Research Facility (SIPRC), which will expand the nation’s capability to enrich stable isotopes for medical, industrial, and research applications. DOE also announced $75 million to support SIPRC with funding provided through President…
October 7, 2022
The DOE IP invites you to join us for virtual "one-on-one" stakeholder meetings on Nov. 1, Nov. 17 and Nov. 21, 2022.
These meetings offer an excellent opportunity for companies and institutions to discuss isotope supply and demand issues firsthand with the federal DOE IP Director and Program Managers and the NIDC staff from Oak Ridge National Laboratory. We are looking forward…
August 22, 2022
Targeted radiation therapy may provide an alternative in treating some blood-borne cancers
The University of Washington and Fred Hutchinson Cancer Center produce and deliver unique cancer therapy for clinical trials.
While no two cancers are the same and every patient reacts differently to treatment, scientists in the Departments of Radiation…
